Dosing, Safety, and Pharmacokinetics (PK) of Combination Therapy with Darolutamide (DARO), Androgen-Deprivation Therapy (ADT), and Docetaxel (DOC) in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mhspc) in the ARASENS Study
ONCOLOGY RESEARCH AND TREATMENT(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined